SCI Pharmtech, Inc. (TPE:4119)
Taiwan
· Delayed Price · Currency is TWD 72.30
+0.40 (0.56%)
May 9, 2025, 2:38 PM CST
SCI Pharmtech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 8, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 8,640 | 10,827 | 11,568 | 9,300 | 8,012 | 6,677 | Upgrade
|
| Market Cap Growth | -12.22% | -6.40% | 24.39% | 16.07% | 20.00% | -21.02% | Upgrade
|
| Enterprise Value | 8,628 | 11,388 | 12,218 | 9,171 | 6,991 | 6,202 | Upgrade
|
| Last Close Price | 72.30 | 90.60 | 95.46 | 82.65 | 71.21 | 59.02 | Upgrade
|
| PE Ratio | 16.67 | 20.25 | 39.25 | 30.12 | 143.85 | 18.54 | Upgrade
|
| Forward PE | 47.25 | 29.34 | 29.34 | 39.47 | 108.50 | - | Upgrade
|
| PS Ratio | 5.49 | 7.11 | 9.61 | 10.34 | 9.27 | 2.48 | Upgrade
|
| PB Ratio | 1.56 | 1.98 | 2.27 | 2.56 | 2.41 | 2.01 | Upgrade
|
| P/TBV Ratio | 1.57 | 1.99 | 2.29 | 2.60 | 2.46 | 2.04 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 8.86 | Upgrade
|
| P/OCF Ratio | 10.16 | 12.58 | 53.62 | 31.36 | 28.59 | 6.87 | Upgrade
|
| EV/Sales Ratio | 5.48 | 7.47 | 10.15 | 10.19 | 8.09 | 2.31 | Upgrade
|
| EV/EBITDA Ratio | 21.43 | 26.50 | 40.23 | 44.10 | 51.56 | 5.24 | Upgrade
|
| EV/EBIT Ratio | 54.52 | 57.43 | 76.22 | 77.09 | 94.91 | 5.90 | Upgrade
|
| EV/FCF Ratio | -40.70 | - | - | - | - | 8.23 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.18 | 0.20 | 0.15 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 1.16 | 2.29 | 3.41 | 2.60 | 0.02 | 0.00 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 0.00 | Upgrade
|
| Asset Turnover | 0.23 | 0.22 | 0.21 | 0.20 | 0.20 | 0.62 | Upgrade
|
| Inventory Turnover | 1.96 | 1.94 | 1.64 | 1.51 | 1.94 | 3.12 | Upgrade
|
| Quick Ratio | 0.81 | 0.97 | 2.35 | 0.61 | 1.39 | 1.33 | Upgrade
|
| Current Ratio | 1.53 | 1.64 | 3.43 | 1.35 | 1.87 | 1.71 | Upgrade
|
| Return on Equity (ROE) | 9.78% | 10.11% | 6.75% | 8.89% | 1.68% | 10.60% | Upgrade
|
| Return on Assets (ROA) | 1.70% | 1.78% | 1.72% | 1.63% | 1.05% | 15.19% | Upgrade
|
| Return on Capital (ROIC) | 1.92% | 1.97% | 1.94% | 1.98% | 1.39% | 19.32% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.00% | 3.20% | 2.60% | 2.80% | 2.10% | 30.50% | Upgrade
|
| Earnings Yield | 6.04% | 4.94% | 2.55% | 3.32% | 0.69% | 5.39% | Upgrade
|
| FCF Yield | -2.45% | -0.80% | -7.03% | -9.37% | -6.13% | 11.29% | Upgrade
|
| Dividend Yield | 2.09% | 1.66% | 1.31% | 0.27% | - | 0.63% | Upgrade
|
| Payout Ratio | 28.62% | 27.94% | 8.09% | - | 71.36% | 128.01% | Upgrade
|
| Buyback Yield / Dilution | -6.86% | -9.44% | -1.87% | -0.08% | 0.49% | 0.26% | Upgrade
|
| Total Shareholder Return | -4.77% | -7.78% | -0.56% | 0.19% | 0.49% | 0.88% | Upgrade
|
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.